Next Article in Journal
The Confounders of Cancer Immunotherapy: Roles of Lifestyle, Metabolic Disorders and Sociological Factors
Previous Article in Journal
Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512
 
 
Comment
Peer-Review Record

Comment on Jun, S.Y.; et al. “Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma” Cancers 2020, 12, 2199

Cancers 2020, 12(10), 2982; https://doi.org/10.3390/cancers12102982
by Paolo Giuffrida 1, Giovanni Arpa 2, Alessandro Vanoli 2 and Antonio Di Sabatino 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2020, 12(10), 2982; https://doi.org/10.3390/cancers12102982
Submission received: 28 August 2020 / Accepted: 13 October 2020 / Published: 15 October 2020

Round 1

Reviewer 1 Report

I kindly disagree with the Authors of this Comment since inflammatory disease-associated and sporadic small bowel adenocarcinomas are genetically and clinically different.

Reviewer 2 Report

This is an odd situation.

The comment is correct. There is an online publication dating from
August 16, 2019 but it was not published formally by the journal until
the March 2020 issue.

This probably is what accounts for the missing citation in the
literature review of the paper published in Cancer.

You are going to need the opinion of a pathologist that specializes in
these types of tumors to determine if this comment should be published,
because this will come down to the significance of the difference
between sporadic versus Crohn's disease association for SBA.
Unfortunately, I am a synthetic chemist, and I am not the right referee
to make that determination. If I were the author's of this comment, I
would not have sent this to you.

Back to TopTop